Riddhi Siddhi Gluco Biols Reports Mixed Financial Results for Q1 FY25

Riddhi Siddhi Gluco Biols, a microcap trading company, has recently announced its financial results for the quarter ending June 2024. The company’s stock has been given a ‘Sell’ call by MarketsMOJO.

According to the financial report, Riddhi Siddhi Gluco Biols has seen a flat performance in the quarter, with a score of 1 out of 20, which is a significant decrease from the previous quarter. However, there are some positive aspects to the company’s financials. The earnings per share (EPS) for the quarter were the highest in the last five quarters, at Rs 32.19. This indicates that the company has been able to generate higher profits for its shareholders.

On the other hand, there are some concerning factors in the financial report. The net sales for the quarter have fallen by -27.84% year on year, indicating a negative trend in the company’s sales. The profit before tax (PBT) has also seen a significant decrease of -100.04% year on year, and the profit after tax (PAT) has fallen by -14.3% year on year. Additionally, the company’s non-operating income is 100.25% of the PBT, which suggests that the company’s income from non-business activities is high, which may not be a sustainable business model.

Overall, Riddhi Siddhi Gluco Biols has reported a mixed financial performance for the quarter ending June 2024. Investors should carefully consider these factors before making any investment decisions.